Rutinib Cream contains the active ingredient Ruxolitinib, which belongs to a class of medications called Janus kinase (JAK) inhibitors. It is primarily used topically to treat certain skin conditions, such as psoriasis and atopic dermatitis.
Rutinib Cream contains the active ingredient Ruxolitinib, which belongs to a class of medications called Janus kinase (JAK) inhibitors. It is primarily used topically to treat certain skin conditions, such as psoriasis and atopic dermatitis.
Ruxolitinib works by blocking the activity of Janus kinases, which are enzymes involved in the signaling pathways that regulate inflammation and immune responses in the body. By inhibiting these pathways, Rutinib Cream helps to reduce inflammation, itching, and redness associated with skin disorders.
This cream is typically applied directly to the affected areas of the skin, following the instructions provided by a healthcare professional. It is important to use Rutinib Cream as directed and to avoid applying it to broken or irritated skin unless specifically instructed otherwise.
Like all medications, Rutinib Cream may cause side effects in some individuals, including skin irritation, burning, or itching at the application site. If any adverse reactions occur or if there is no improvement in your skin condition after using the cream as directed, consult your healthcare provider for further guidance.
| Composition | Regorafenib |
|---|
